Wir sind mit live!
Mehr erfahren
Hologic
HOLX
HOLX
Nicht mehr börsennotiert
HOLX wurde am 6. April 2026 von der Börse genommen.
Profil: Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
Mitarbeiter: 7.070
Nachrichten
Positiv
Neutral
Negativ
Stimmung
3 Monate
Positiv
0 %
Neutral
0 %
Negativ
0 %
Kursdiagramme mit Lightweight Charts™ umgesetzt